Monte Rosa Therapeutics, Inc. earnings per share and revenue

GLUE earnings per share for the last quarter are 0.57 USD whereas the estimation was -0.00 USD which accounts for 21674.56% surprise. Company revenue for the same period amounts to 84.93 M USD despite the estimated figure of 41.68 M USD. Estimated earnings per share for the next quarter are -0.38 USD, and revenue is expected to reach 7.38 M USD. Also watch annual changes over time to get a bigger picture of GLUE earnings per share and revenue dynamics.